Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 47 Total
ULY - Urgent.ly Inc - Stock Price Chart
TickerULY [NASD]
CompanyUrgent.ly Inc
CountryUSA
IndustrySoftware - Application
Market Cap24.68MEPS (ttm)5.69
P/E0.33EPS this Y-110.17%
Forward P/E-EPS next Y58.14%
PEG-EPS past 5Y-
P/S0.13EPS next 5Y-
P/B-EPS Q/Q654.07%
Dividend-Sales Q/Q-13.59%
Insider Own-Inst Own19.21%
Insider Trans-Inst Trans-
Short Float-EarningsMar 14/a
Analyst Recom1.00Target Price5.00
Avg Volume84.36K52W Range1.83 - 12.00
Urgent.ly, Inc. develops a mobile application for roadside assistance. The firm?s industry solutions include insurance, automotive, financial, parking, wireless, fleets and rental. It specializes in on demand mobile services, mobile apps, mobile web, roadside assistance, towing services, and global digital roadside assistance solutions. The company was founded by Ric Fleisher, Surendra Goel, Luke Kathol, Lokesh Kumar, Rick Robinson and Christopher Spanos in 2013 and is headquartered in Vienna, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ben VolkowDirectorMar 19 '24Sale2.212,5785,687559,944Mar 21 05:49 PM
Ben VolkowDirectorMar 18 '24Sale2.2224,50054,378562,522Mar 21 05:49 PM
Ben VolkowDirectorDec 12 '23Sale3.434,27814,674587,022Dec 14 06:09 PM
Geisse Andrew MDirectorNov 17 '23Buy3.9925,00099,81861,046Nov 21 09:00 PM
Pollock RyanDirectorOct 19 '23Option Exercise0.09151,10913,600513,323Oct 23 09:21 PM
WNS - WNS Holdings Limited ADR - Stock Price Chart
TickerWNS [NYSE]
CompanyWNS Holdings Limited ADR
CountryIndia
IndustryInformation Technology Services
Market Cap2.37BEPS (ttm)3.32
P/E15.21EPS this Y12.41%
Forward P/E11.02EPS next Y5.69%
PEG1.35EPS past 5Y10.56%
P/S1.82EPS next 5Y11.29%
P/B2.88EPS Q/Q17.51%
Dividend-Sales Q/Q6.41%
Insider Own11.62%Inst Own93.18%
Insider Trans0.00%Inst Trans2.19%
Short Float1.27%EarningsJan 18/b
Analyst Recom1.17Target Price77.40
Avg Volume358.61K52W Range49.94 - 94.96
WNS (Holdings) Ltd. engages in the provision of business process management solutions. Its services include industry-specific offerings, customer interaction, finance and accounting, human resources, procurement, and research and analytics. It operates through the WNS Global BPM and WNS Auto Claims BPM segments. The WNS Global BPM is delivered out of its delivery centers in China Costa Rica, India, the Philippines, Poland, Romania, South Africa, Sri Lanka, the United Kingdom, and the U.S. The WNS Auto Claims BPM segment offers fault and non-fault repairs and legal services in relation to personal injury claims. The company was founded by Alan Stephen Dunning, David Charles Tibble and Neeraj Bhargava on February 18, 2002 and is headquartered in Mumbai, India.
BBLG - Bone Biologics Corp - Stock Price Chart
TickerBBLG [NASD]
CompanyBone Biologics Corp
CountryUSA
IndustryMedical Devices
Market Cap1.13MEPS (ttm)-76.57
P/E-EPS this Y11.41%
Forward P/E-EPS next Y-4.75%
PEG-EPS past 5Y42.24%
P/S-EPS next 5Y-
P/B0.39EPS Q/Q-120.70%
Dividend-Sales Q/Q-
Insider Own7.84%Inst Own2.08%
Insider Trans0.00%Inst Trans-69.56%
Short Float6.34%Earnings-
Analyst Recom1.00Target Price300.00
Avg Volume246.76K52W Range2.03 - 86.81
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walsh Deina HChief Financial OfficerSep 13 '23Buy0.648,0005,12015,000Sep 14 11:08 AM
Frelick JeffChief Executive OfficerSep 11 '23Buy0.699,5006,53017,204Sep 12 11:34 AM
Walsh Deina HChief Financial OfficerSep 06 '23Buy0.717,0004,9677,000Sep 07 10:45 AM
Frelick JeffChief Executive OfficerAug 31 '23Buy0.667,6005,0207,704Sep 05 05:05 PM
ELPC - Cia Paranaense De Energia Copel ADR - Stock Price Chart
TickerELPC [NYSE]
CompanyCia Paranaense De Energia Copel ADR
CountryBrazil
IndustryUtilities - Diversified
Market Cap2.83BEPS (ttm)0.63
P/E10.64EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y2.58%
P/S0.64EPS next 5Y-
P/B1.02EPS Q/Q37.62%
Dividend-Sales Q/Q4.94%
Insider Own-Inst Own0.79%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume74.69K52W Range6.74 - 8.25
Jan-21-24 08:33AM 16 Most Profitable New Stocks Today (Insider Monkey)
Companhia Paranaense de Energia engages in the generation, transmission, distribution and sale of electricity. It operates through the following segments: Power Generation and Transmission (GET), Power Distribution (DIS), Telecommunications (TEL), GAS, Power Sale (COM), and Holding Company (HOL). The GET segment include production of electricity from hydraulic, wind, and thermal projects (GER) and also provides services of transmission and transformation of electric power. The DIS segment comprises public electricity distribution services. The TEL segment offers telecommunications and general communication services. The GAS segment encompasses public service of piped natural gas distribution. The HOL segment participate in other companies. The company was founded on October 26, 1954 and is headquartered in Curitiba, Brazil.
SPRC - SciSparc Ltd - Stock Price Chart
TickerSPRC [NASD]
CompanySciSparc Ltd
CountryIsrael
IndustryBiotechnology
Market Cap4.34MEPS (ttm)1.94
P/E0.91EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-62.50%
P/S1.31EPS next 5Y-
P/B0.12EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own0.02%Inst Own2.56%
Insider Trans0.00%Inst Trans-
Short Float5.67%Earnings-
Analyst Recom1.00Target Price520.00
Avg Volume1.09M52W Range1.73 - 23.66
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
AMLI - American Lithium Corp - Stock Price Chart
TickerAMLI [NASD]
CompanyAmerican Lithium Corp
CountryCanada
IndustryOther Industrial Metals & Mining
Market Cap145.97MEPS (ttm)-0.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y20.26%
P/S-EPS next 5Y-
P/B1.15EPS Q/Q-94.90%
Dividend-Sales Q/Q-
Insider Own3.67%Inst Own8.33%
Insider Trans0.00%Inst Trans-
Short Float0.93%EarningsJan 16/b
Analyst Recom1.00Target Price4.77
Avg Volume477.11K52W Range0.66 - 2.49
American Lithium Corp. is an exploration stage company. It engages in the acquisition, exploration, and development of lithium deposits. The firm is focused on exploring and developing the TLC Lithium, Falchani Lithium, and Macusani Uranium projects. The company was founded on February 25, 1974 and is headquartered in Vancouver, Canada.
PRTA - Prothena Corporation plc - Stock Price Chart
TickerPRTA [NASD, RUT]
CompanyProthena Corporation plc
CountryIreland
IndustryBiotechnology
Market Cap1.33BEPS (ttm)-2.80
P/E-EPS this Y-78.59%
Forward P/E-EPS next Y12.22%
PEG-EPS past 5Y6.83%
P/S14.56EPS next 5Y34.07%
P/B2.37EPS Q/Q-1169.13%
Dividend-Sales Q/Q-99.37%
Insider Own13.65%Inst Own98.80%
Insider Trans-0.39%Inst Trans-4.11%
Short Float13.47%EarningsFeb 15/a
Analyst Recom1.40Target Price67.78
Avg Volume827.68K52W Range24.28 - 79.65
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walker Karin LChief Accounting OfficerJan 24 '24Option Exercise13.535,00067,6505,000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerJan 24 '24Sale34.005,000170,0000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerDec 20 '23Option Exercise13.535,00067,6505,000Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerDec 20 '23Sale37.195,000185,9520Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerNov 30 '23Option Exercise13.535,00067,6505,000Nov 30 06:24 PM
12345